As we reported, Ontario has introduced legislation that will require pharmaceutical and medical device manufacturers to disclose financial relationships with healthcare professionals and organizations to the government.
The legislation has passed second reading and has been referred to committee. The Standing Committee on General Government will hold public hearings on November 15, 16, 20, and 22, 2017.
Those wishing to make oral submission must provide contact information by November 8 (to speak on November 15 or 16) or November 15 (to speak on November 20 or 22). Written submissions will be accepted until noon on November 23, 2017.
Details can be found in the notice of hearing.
Link:
Bill 160, Strengthening Quality and Accountability for Patients Act, 2017
